-
HPA055473-25
Anti-PIDD1 p53-induced death domain protein 1, 25ul UN 1687 (C08-0242-869)
Price: $830.56List Price: $922.85Anti-PIDD1 p53-induced death domain protein 1, 25ul UN 1687 -
SML3377-5MG
BG-3 (C15-1720-876)
Price: $248.76List Price: $276.40Biochem/physiol Actions BG-3 is a cell penetrant, potent and selective inhibitor of Pax2 (paired-box 2) that inhibits Pax2 transactivation ability. BG-3 inhibit the ability of Pax proteins to recruit PTIP and promote H3K4 methylation at Pax -
SML3377-25MG
BG-3 (C15-1720-877)
Price: $802.70List Price: $891.89Biochem/physiol Actions BG-3 is a cell penetrant, potent and selective inhibitor of Pax2 (paired-box 2) that inhibits Pax2 transactivation ability. BG-3 inhibit the ability of Pax proteins to recruit PTIP and promote H3K4 methylation at Pax -
SML1635-5MG
BRASSININ (C15-1723-640)
Price: $194.78List Price: $216.43Biochem/physiol Actions Brassinin is a phytoalexin isolated from cruciferous vegetables that exhibits anticancer, chemopreventive, antiproliferative and antifungal activities. In lung cancer cells, brassinin inhibits constitutive and -
16245-1
CX-6258-1 mg
Price: $161.42List Price: $179.36A potent, reversible, orally bioavailable inhibitor of Pim-1, -2, and -3 (IC<sub>50</sub>s = 5, 25, and 16 nM, respectively) dose-dependently blocks the phosphorylation of the Pim targets Bad, 4E-BP1, and NKX3.1 acts synergistically with -
16245-10
CX-6258-10 mg
Price: $413.27List Price: $459.19A potent, reversible, orally bioavailable inhibitor of Pim-1, -2, and -3 (IC<sub>50</sub>s = 5, 25, and 16 nM, respectively) dose-dependently blocks the phosphorylation of the Pim targets Bad, 4E-BP1, and NKX3.1 acts synergistically with -
16245-25
CX-6258-25 mg
Price: $824.03List Price: $915.59A potent, reversible, orally bioavailable inhibitor of Pim-1, -2, and -3 (IC<sub>50</sub>s = 5, 25, and 16 nM, respectively) dose-dependently blocks the phosphorylation of the Pim targets Bad, 4E-BP1, and NKX3.1 acts synergistically with -
16245-5
CX-6258-5 mg
Price: $278.69List Price: $309.65A potent, reversible, orally bioavailable inhibitor of Pim-1, -2, and -3 (IC<sub>50</sub>s = 5, 25, and 16 nM, respectively) dose-dependently blocks the phosphorylation of the Pim targets Bad, 4E-BP1, and NKX3.1 acts synergistically with -
124015-1MG
INSOLUTION AKT INHIBITOR IV - CALBIOCHEM
Price: $351.97List Price: $391.07A cell-permeable benzimidazole compound that inhibits Akt phosphorylation/activation presumably by targeting the ATP binding site of a kinase upstream of Akt, but downstream of PI3K. Shown to block Akt-mediated FOXO1a nuclear export (IC 50 = 625 -
SAB1411969-100UG
MONOCLONAL ANTI-PIM1 ANTIBODY PRODUCED IN MOUSE (C15-1746-192)
Price: $980.46List Price: $1,089.40General description The protooncogene PIM1 encodes a protein kinase upregulated in prostate cancer (Dhanasekaran et al., 2001 [PubMed 11518967]). -
SAB1411967-100UG
MONOCLONAL ANTI-PIM1 ANTIBODY PRODUCED IN MOUSE (C15-1746-193)
Price: $980.46List Price: $1,089.40General description The protooncogene PIM1 encodes a protein kinase upregulated in prostate cancer (Dhanasekaran et al., 2001 [PubMed 11518967]). -
SAB1411966-100UG
MONOCLONAL ANTI-PIM1 ANTIBODY PRODUCED IN MOUSE (C15-1746-194)
Price: $980.46List Price: $1,089.40General description The protooncogene PIM1 encodes a protein kinase upregulated in prostate cancer (Dhanasekaran et al., 2001 [PubMed 11518967]).